Aurinia Pharmaceuticals AUPH Payments To Acquire Other Productive Assets
Payments To Acquire Other Productive Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherProductiveAssets.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's payments to acquire other productive assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's payments to acquire other productive assets?
- Aurinia Pharmaceuticals (AUPH) reported payments to acquire other productive assets of $39K in Q1 2026.
- How has Aurinia Pharmaceuticals's payments to acquire other productive assets changed year-over-year?
- Aurinia Pharmaceuticals's payments to acquire other productive assets increased by 129.4% year-over-year, from $17K to $39K.
- What is the long-term trend for Aurinia Pharmaceuticals's payments to acquire other productive assets?
- Over 2 years (2022 to 2025), Aurinia Pharmaceuticals's payments to acquire other productive assets has grown at a -7.1% compound annual growth rate (CAGR), from $292K to $252K.
- What does payments to acquire other productive assets mean?
- This captures cash expenditures for long-term assets, such as equipment or infrastructure, intended to support ongoing business operations. It serves as a proxy for the company's investment in its own productive capacity and future growth potential. Monitoring this helps investors evaluate the firm's commitment to maintaining and expanding its operational footprint.